🧬 AI: The New Guardian of Drug Safety
Adverse drug reactions (ADRs) are a leading cause of hospitalizations and fatalities. Traditional methods often detect these issues post-market, sometimes too late. Enter Artificial Intelligence (AI), revolutionizing how we predict and prevent side effects.
AI analyzes vast datasets—including chemical structures, electronic health records, and genomic profiles—to identify potential risks before a drug reaches patients. Tools like IBM Watson Health and BenevolentAI are already collaborating with pharmaceutical companies to enhance drug safety.
While challenges like data bias and privacy concerns persist, the integration of AI into pharmacovigilance promises a future of safer, more personalized medicine.
🔗 Read more: https://www.nexthorizon.space/....2025/04/predicting-d
#aiinhealthcare #drugsafety #pharmacovigilance #medicalinnovation
